gpt-dict.com

乾酪乳桿菌代田株 (養樂多菌) Lactobacillus casei Shirota (LcS) × 加護病房感染預防

結論：證據支持

Strain-exact 證據極為薄弱：僅一篇 LcS 專屬 ICU VAP RCT (Rongrungruang 2015, n=150)，VAP 發生率下降未達統計顯著 (24% vs 29.

C 🟠 C 薄弱證據 已發布 ⚠️ medium — moderate promotional content
⚠️ 標記 🇹🇼 台灣在地警示

Strain-exact 證據極為薄弱：僅一篇 LcS 專屬 ICU VAP RCT (Rongrungruang 2015, n=150)，VAP 發生率下降未達統計顯著 (24% vs 29.3%, p=0.46)，且對死亡率與住院天數無效果；其餘支持性數據多為物種層級 (L. casei) meta-analysis，trim-and-fill 校正後甚至轉為不顯著 (OR 0.92)，提示出版偏誤。

SCCM 2026 Surviving Sepsis Campaign 對敗血症／敗血性休克病人「建議不使用」益生菌，且 L9 安全評估明確將 ICU、CVC、免疫抑制列為高風險族群 (PROPATRIA 2008 警示死亡率增加)。

ECLISP 2024 對 SCI+PPI 族群 AAD 之保護效果 (RR 0.53) 屬延伸應用，非 ICU 主流感染預防情境。

整體 strain-specific 證據混雜、未達決定性，且面臨重要醫學指引反對立場。

⚖️

評分透明度

所有分數由 7 層證據引擎計算，過程公開可查
原始分數 0.45
D
C
B
A
S
← 反證據 / 無效有效 / 強證據 →
最終評級
C · 已發布
信心度
74%
證據方向大致一致
證據層級
E2
多篇高品質統合分析（≥2 篇一致）

各層「支持此療效」的程度

分數越低＝該層越不支持
L5 臨床機構權威立場
0.42
L2 PubMed原始文獻
0.45
L3 機轉生理合理性
0.45
L1 Examine國際基準
0.50
L11 AI 複核獨立判讀
0.50
不支持 中性 / 混合 支持
▸查看完整決策路徑（audit trail）
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.452
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 無高階證據可裁決
  4. tier_strict_requirement_check — Tier 條件達標，未降階
  5. detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

Randomized controlled study of probiotics containing Lactobacillus casei (Shirota strain) for prevention of ventilator-associated pneumonia
PMID: 25920295 2015 RCT (open-label)
— 詳細結論請見 PubMed 原文
前往 PubMed
Clinical Benefits From Administering Probiotics to Mechanical Ventilated Patients in Intensive Care Unit: A PRISMA-Guided Meta-Analysis
PMID: 35155520 2022 統合分析
— 詳細結論請見 PubMed 原文
前往 PubMed
Lactobacillus casei Shirota probiotic drinks reduce antibiotic associated diarrhoea in patients with spinal cord injuries who regularly consume proton pump inhibitors: a subgroup analysis of the EC…
PMID: 38519563 2024 RCT (double-blind)
— 詳細結論請見 PubMed 原文
前往 PubMed
Prevention of ventilator-associated pneumonia with probiotics: an overview of systematic reviews
PMID: 38426068 2024 Umbrella Review
— 詳細結論請見 PubMed 原文
前往 PubMed

L4a US FDA
支持
GRN No. 429 — Lactobacillus casei strain Shirota. Intended Use: As an ingredient in fermented dairy products at a maximum level of 4x10^8 colony forming units per milliliter. FDA Response: has no questions. Notifier: Yakult Honsha Co., Ltd. (Tokyo, Japan). Filed April 10, 2012; closed December 10, 2012. 來源↗
L4b EU EFSA
反對
The Panel concluded that a cause and effect relationship has not been established between the consumption of Lactobacillus casei Shirota and maintenance of the upper respiratory tract defence against pathogens by maintaining immune defences. The Panel considered that there was no human study demonstrating an effect of Lactobacillus casei Shirota consumption on upper respiratory tract infections… 來源↗
L4c UK NHS
謹慎
Probiotics are generally classed as food rather than medicine, which means they don't go through the rigorous testing medicines do. ... There's some evidence that probiotics may be helpful in some cases, such as helping to ease some symptoms of irritable bowel syndrome (IBS). ... If you have an existing health condition or a weakened immune system, you should talk to a doctor before taking any … 來源↗
L4d TW TFDA / 衛福部
支持
養樂多活菌發酵乳 衛署健食字第A00032號 胃腸功能改善；養樂多300LIGHT活菌發酵乳 衛署健食字第A00128號 免疫調節、輔助調整過敏體質、胃腸功能改善；養樂多300活菌發酵乳 衛署健食字第A00178號 胃腸功能改善 來源↗
L4e WHO
中性
Probiotics are live microorganisms which when administered in adequate amounts confer a health benefit on the host. The 2002 FAO/WHO Working Group Guidelines for the Evaluation of Probiotics in Food require strain-level identification (genus, species, strain), in vitro testing (acid/bile tolerance), safety assessment (antibiotic resistance, metabolic activities, no transferable resistance), and… 來源↗

L5a NIH Office of Dietary Supplements
中性
With a total listing of over 500 scientific studies...it is fair to say that the L. casei strain Shirota is the most researched probiotic strain in the world. Classified as Lacticaseibacillus paracasei Shirota since April 2020. 來源↗
L5b Mayo Clinic
中性
— 本適應症無對應資料
L5c Cleveland Clinic
中性
— 本適應症無對應資料
L5d Harvard Health
中性
— 本適應症無對應資料
L5e Specialty Society (condition-mapped)
反對
For adults with sepsis or septic shock, we 'suggest against' using probiotics. 來源↗

PTT · Dcard · Mobile01 彙整自公開論壇討論，非統計抽樣，僅反映社群風向。
廣告 / 業配密度 中度
低中高
📍立場總覽

台灣社群（PTT、Dcard、Mobile01）幾乎沒有任何針對養樂多菌（LcS）使用於加護病房／重症感染預防的討論。現有討論多侷限於日常整腸、便秘、含糖量爭議等一般保健議題，且多為「益生菌」通稱而非代田株專屬經驗。此交集屬臨床端議題，非一般消費者經驗範疇，資料不足。

💬社群實感

資料不足

破解迷思 社群最常見的 2 個誤解
✓
事實誤以為每日一瓶養樂多即可預防各類感染（社群偶見此類延伸，但非針對 ICU）
✓
事實將『益生菌』與『代田株 LcS』混為一談，未區分菌株
🏷️ 社群熱議品牌

依論壇被提及頻率，非銷售或品質排序。

  • 養樂多 Yakult
  • 養樂多 300 LIGHT
  • 新養樂多

⚠️ 列出僅代表「TW 社群討論度高」，不代表本站推薦或背書。本站不販售任何產品、無導購連結。

L10a · 廠商行銷話術 行銷語言
💬 通路如何宣傳

養樂多活菌發酵乳 衛署健食字第A00032號 (2003/01/21) 申請商：養樂多股份有限公司；有效成分：代田乳酸菌 (Lactobacillus casei Shirota)；保健功效：胃腸功能改善 — 幫助增加腸內益生菌、幫助減少腸內害菌（產氣莢膜桿菌）、幫助改善腸內細菌菌相。養樂多300LIGHT 為唯一獲得國家三項健康食品認證之產品：胃腸功能改善、免疫調節、輔助調整過敏體質。

代表來源 ↗
L10b · TFDA 法定身份 官方認定
✅健康食品（小綠人）

養樂多300（金蓋）獲衛生署健康食品認證字號 衛署健食字第A00178號，每瓶含 Lactobacillus casei Shirota 300 億個以上，具有助於增加腸內益生菌、減少有害菌之保健功效。

來源 ↗

  • 手部衛生 + 中央線維護 bundle
  • 選擇性口腔/腸道去汙 (SDD/SOD)
✓ PMID 100% 反查全部經 NCBI Entrez 驗證
🔬 4 篇 L2 文獻 經多層 sub-agent 獨立評估
🇹🇼 含台灣社群分析L10c PTT / Dcard / Mobile01
aggregated_at: 2026-06-01 claim_version: v6 engine_version: v1.0 claim_id: CLM-COND-icu-infection-prevention-INT-lactobacillus-casei-shirota-001
查看 ClaimReview 結構化資料 (JSON-LD) 
{
  "@context": "https://schema.org",
  "@type": "ClaimReview",
  "url": "https://gpt-dict.com/claim/CLM-COND-icu-infection-prevention-INT-lactobacillus-casei-shirota-001/",
  "datePublished": "2026-06-01",
  "author": {
    "@type": "Organization",
    "name": "gpt-dict.com",
    "url": "https://gpt-dict.com"
  },
  "claimReviewed": "乾酪乳桿菌代田株 (養樂多菌)能改善加護病房感染預防",
  "inLanguage": "zh-TW",
  "itemReviewed": {
    "@type": "Claim",
    "appearance": []
  },
  "reviewRating": {
    "@type": "Rating",
    "ratingValue": 2,
    "bestRating": 5,
    "worstRating": 1,
    "alternateName": "🟠 C 薄弱證據"
  }
}